Outcomes of Image-Guided Moderately Hypofractionated Radiotherapy for Stage III Non-Small-Cell Lung Cancer.
Yang ZhangZongjuan LiYi-Xing ChenHan XiaoYongkang ZhouShisuo DuZhao Chong ZengPublished in: Journal of oncology (2021)
For Chinese stage III NSCLC patients, image-guided hypo-RT offers favorable prognosis, and the treatment toxicity was totally acceptable. This radiation modality deserves further prospective clinical trials.
Keyphrases
- clinical trial
- radiation therapy
- end stage renal disease
- ejection fraction
- small cell lung cancer
- newly diagnosed
- early stage
- chronic kidney disease
- oxidative stress
- prognostic factors
- radiation induced
- randomized controlled trial
- squamous cell carcinoma
- patient reported outcomes
- study protocol
- replacement therapy